Champions Oncology, Inc. announced its financial results for Q3 fiscal 2026, reporting total revenue of $16.6 million, a 32% increase in study service revenue. The company remains on track for annual growth and positive adjusted EBITDA.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.